Graduate School of Biomedical Sciences, University of Texas MD Anderson Cancer Center UTHealth Houston, Houston, Texas; Department of Imaging Physics, University of Texas MD Anderson Cancer Center, Houston, Texas.
Department of Imaging Physics, University of Texas MD Anderson Cancer Center, Houston, Texas.
Int J Radiat Oncol Biol Phys. 2024 Jan 1;118(1):231-241. doi: 10.1016/j.ijrobp.2023.07.016. Epub 2023 Aug 8.
The aim of this study was to investigate the dosimetric and clinical effects of 4-dimensional computed tomography (4DCT)-based longitudinal dose accumulation in patients with locally advanced non-small cell lung cancer treated with standard-fractionated intensity-modulated radiation therapy (IMRT).
Sixty-seven patients were retrospectively selected from a randomized clinical trial. Their original IMRT plan, planning and verification 4DCTs, and ∼4-month posttreatment follow-up CTs were imported into a commercial treatment planning system. Two deformable image registration algorithms were implemented for dose accumulation, and their accuracies were assessed. The planned and accumulated doses computed using average-intensity images or phase images were compared. At the organ level, mean lung dose and normal-tissue complication probability (NTCP) for grade ≥2 radiation pneumonitis were compared. At the region level, mean dose in lung subsections and the volumetric overlap between isodose intervals were compared. At the voxel level, the accuracy in estimating the delivered dose was compared by evaluating the fit of a dose versus radiographic image density change (IDC) model. The dose-IDC model fit was also compared for subcohorts based on the magnitude of NTCP difference (|ΔNTCP|) between planned and accumulated doses.
Deformable image registration accuracy was quantified, and the uncertainty was considered for the voxel-level analysis. Compared with planned doses, accumulated doses on average resulted in <1-Gy lung dose increase and <2% NTCP increase (up to 8.2 Gy and 18.8% for a patient, respectively). Volumetric overlap of isodose intervals between the planned and accumulated dose distributions ranged from 0.01 to 0.93. Voxel-level dose-IDC models demonstrated a fit improvement from planned dose to accumulated dose (pseudo-R increased 0.0023) and a further improvement for patients with ≥2% |ΔNTCP| versus for patients with <2% |ΔNTCP|.
With a relatively large cohort, robust image registrations, multilevel metric comparisons, and radiographic image-based evidence, we demonstrated that dose accumulation more accurately represents the delivered dose and can be especially beneficial for patients with greater longitudinal response.
本研究旨在探讨基于 4 维 CT(4DCT)的纵向剂量累积在接受标准分割调强放疗(IMRT)的局部晚期非小细胞肺癌患者中的剂量学和临床效果。
从一项随机临床试验中回顾性选择了 67 例患者。将他们的原始 IMRT 计划、计划和验证 4DCT 以及约 4 个月后的治疗后 CT 导入商业治疗计划系统。实施了两种可变形图像配准算法进行剂量累积,并评估了其准确性。比较了使用平均强度图像或相位图像计算的计划和累积剂量。在器官水平上,比较了平均肺剂量和 2 级以上放射性肺炎的正常组织并发症概率(NTCP)。在区域水平上,比较了肺亚段的平均剂量和等剂量间隔之间的体积重叠。在体素水平上,通过评估剂量与射线照相图像密度变化(IDC)模型的拟合来比较估计的递送达剂量的准确性。还根据计划和累积剂量之间的 NTCP 差异(|ΔNTCP|)的大小,为子队列比较了剂量-IDC 模型的拟合。
量化了可变形图像配准的准确性,并考虑了体素水平分析的不确定性。与计划剂量相比,累积剂量平均导致肺剂量增加<1Gy,NTCP 增加<2%(对于患者,最大分别为 8.2Gy 和 18.8%)。计划和累积剂量分布之间的等剂量间隔的体积重叠范围从 0.01 到 0.93。体素水平的剂量-IDC 模型显示,从计划剂量到累积剂量的拟合得到了改善(伪 R 值增加了 0.0023),对于|ΔNTCP|≥2%的患者,进一步改善了拟合。
通过相对较大的队列、稳健的图像配准、多水平度量比较和射线照相图像为基础的证据,我们证明了剂量累积更准确地代表了递送达剂量,并且对于纵向反应较大的患者尤其有益。